SCHEMBL28410508

SCHEMBL28410508

CCC1(OC(N)=O)CC=CC1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10120696 0.80
SCHEMBL5222511 0.77 ALOX15 (0.36) ALOX15
SCHEMBL28236679 0.75 ALOX15 (0.34) ALOX15
SCHEMBL26633641 0.72 KDM4E (0.40) ALOX15
SCHEMBL28228578 0.67 PKM (0.30)
SCHEMBL5220115 0.65 ALOX15 (0.33) ALOX15
SCHEMBL3831144 0.64
SCHEMBL14690356 0.64
SCHEMBL3825814 0.64 ALOX15 (0.31) ALOX15
SCHEMBL28134301 0.62 KDM4E (0.31) ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111471021-B Substituted diamino carboxamides and diamino carbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2024-04-02 CN disclosed
CN-111499580-A Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-08-07 CN disclosed
CN-111471021-A Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-07-31 CN disclosed
CN-105001165-B Substituted diaminopyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-06-23 CN disclosed
CN-106946795-B Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-06-02 CN disclosed